Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

MELOXICAM TABLETS

Awarded
SPE2DP26F9155Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP26F9155 is a delivery order issued on August 27, 2026, to DMS Pharmaceutical Group Inc for the procurement of Meloxicam Tablets. This specific order, valued at 270.00 dollars, is designated for delivery to the USS Arleigh Burke DDG 51 and is identified by National Stock Number 6505015413243. This delivery order operates under the broader base administrative contract SPE2DX25D9900, which was awarded by the DLA Troop Support Medical Supply Chain on April 2, 2025. The overarching base contract has a total award value of 19,999,999.00 dollars and incorporates standard federal acquisition regulations to govern the supply of medical materials.

General Info

Contract Value

$270

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

(2)

SPE2DP-26-F-9155 - Order for Supplies or Services

PDF•3 pages•task-order-award

SPE2DX-25-D-9900 - DMS Pharmaceutical Group Inc

PDF•4 pages•award

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9155 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $270.00 Award Date: 08-27-2026 Delivery order under: SPE2DX25D9900 Line items: - MELOXICAM TABLETS (NSN/Part 6505015413243, PR 7018084120)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
IOHEXOL INJECTION, U
Solicitation # SPE2DP-26-T-5185
This fixed-price solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, seeks quotes for the procurement of IOHEXOL INJECTION, USP. The product is a radiological contrast media consisting of 300mg/ml injections provided in 150ml polymer bottles, with a unit of issue defined as a box. The requirement is split into two line items, each for a quantity of two boxes, with a total of four boxes requested. Delivery is required within five days of order, with specific destination delivery dates set for June 18 and June 22, 2026. Shipments are directed to the Naval Med Readiness Logistics Command in Williamsburg, Virginia, and the USS Iwo Jima LHD 7. The contract mandates strict adherence to quality and safety standards, including USP pharmacopeia standards and a non-extendable 36-month shelf-life requirement. Packaging must be commercial and compliant with DLA packaging requirements, specifically RP001 and Medical Marking Standard No. 1. For hazardous materials, suppliers must provide Safety Data Sheets and labels conforming to the Hazard Communication Standard and the UN Globally Harmonized System. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic sourcing, and the safeguarding of covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 2 days
View Details
NAICS: 424210
New
DIBBS
IOPAMIDOL INJECTION
Solicitation # SPE2DP-26-T-5273
Solicitation SPE2DP-26-T-5273, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of 10 packages of Iopamidol Injection (NSN 6505-01-657-0664). Each package consists of ten 100 ML single dose bottles. The product is not for intrathecal use and must be stored at 20-25 C (68-77 F) and protected from light. The requirement specifies a non-extendable shelf life of 24 months. Delivery is required within 20 days after receipt of order, with the original required delivery date set for September 29, 2026. The shipping terms are FOB Destination, with both inspection and acceptance occurring at the destination point, specifically Travis AFB, California. The contract mandates strict adherence to medical marking and packaging standards. Material must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions, although general packaging and labeling may still reference MIL-STD-129. Packaging must follow ASTM D3951 for non-hazardous materials or TQ requirement IP025 if the material is deemed hazardous per FED-STD-313. All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment, and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic material restrictions, and the Buy American Act. Quotes are to be submitted via the DIBBS portal.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-5290
This solicitation, issued by DLA Troop Support Medical Supply Chain Pharm FSA under number SPE2DP-26-T-5290, is a request for quotations for Compound Benzoin Tincture, USP. The product is an over-the-counter topical solution for external use, containing 1000 mg of benzoin resin per 1 ml and 77 percent alcohol as an inactive ingredient. The requirement consists of two line items totaling five 16-ounce bottles. This is a fixed-price acquisition with a 20-day delivery requirement, and the items are to be delivered FOB Destination to specified locations, including sites in Germany and California. The contract includes stringent technical, safety, and quality requirements. The item is classified as a Type I (Code Q) item with a 36-month shelf life, requiring a minimum of 31 months of remaining shelf life at the time of receipt. Because the tincture is flammable and contains alcohol, it is classified as hazardous material; therefore, the contractor must provide a current Material Safety Data Sheet (MSDS) with each shipment and ensure packaging complies with 49 CFR and ICAO or IMDG regulations. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Additionally, the procurement is subject to domestic preference regulations, including the Buy American Act and the Berry Amendment, and requires compliance with cybersecurity standards for safeguarding covered defense information. Quotations must be submitted via the DIBBS system by the October 5, 2026, deadline.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS